First tests begin on new diabetes treatment
NCT ID NCT06945406
Summary
This is an early-stage study to check the safety and side effects of a new drug called LY4057996 in healthy volunteers and people with Type 1 or Type 2 diabetes. Researchers will give the drug as an injection under the skin or into a vein and measure how the body processes it. The main goal is to see if the drug is safe and how it affects blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Profil Institut für Stoffwechselforschung
RECRUITINGNeuss, 41460, Germany
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.